Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGIPLTF Equity-to-Asset is 0.00 as of . 20. Among 851 Medical Devices & Instruments companies, Implantica AG ranks worse than 117508.7% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Implantica AG's Total Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil. Implantica AG's Total Assets for the quarter that ended in . 20 was $0.00 Mil.
The historical rank and industry rank for Implantica AG's Equity-to-Asset or its related term are showing as below:
IPLTF's Equity-to-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.64 * Ranked among companies with meaningful Equity-to-Asset only.
Implantica AG (OTCPK:IPLTF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Implantica AG Equity-to-Asset Related Terms
Implantica AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Implantica AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Equity-to-Asset Chart
Implantica AG Annual Data
Trend
Equity-to-Asset
Implantica AG Semi-Annual Data
Equity-to-Asset
IPLTF vs : Equity-to-Asset Comparison
For the Medical Devices subindustry, Implantica AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Implantica AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Implantica AG's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG (IPLTF) has a Equity-to-Asset of 0.00 as of . 20. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 851 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Equity-to-Asset too high?
Implantica AG's current Equity-to-Asset is 0.00. Based on the distribution chart, Implantica AG ranks #999999 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Implantica AG's Equity-to-Asset compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 851 companies for Equity-to-Asset. This places Implantica AG in the lower half of its industry. The industry median Equity-to-Asset is 0.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Equity-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (IPLTF) has a current Equity-to-Asset of 0.00. The current Equity-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Implantica AG (IPLTF), the current Equity-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IPLTF has been successfully added to your 
